Hyperpolarised MRI of cardiac inflammation and repair. (23rd February 2017)
- Record Type:
- Journal Article
- Title:
- Hyperpolarised MRI of cardiac inflammation and repair. (23rd February 2017)
- Main Title:
- Hyperpolarised MRI of cardiac inflammation and repair
- Authors:
- Lewis, Andrew
Miller, Jack
Rider, Oliver
Choudhury, Robin
Neubauer, Stefan
Carr, Carolyn
Tyler, Damian - Abstract:
- Abstract: Background: Myocardial infarction remains a major killer despite optimised reperfusion systems, highlighting a need for novel therapeutic approaches administered in the days after the event. Inflammation in healing myocardium is one such therapeutic target, though clinical exploration has been hampered by the absence of imaging biomarkers. We hypothesised that metabolic reprogramming in activated macrophages within healing myocardium could be detected by use of hyperpolarised [1- 13 C]pyruvate MRI. Methods: Experimental myocardial infarction was induced in rodents before hyperpolarised [1- 13 C]pyruvate MRI at days 3 or 7, using a 7T MRI scanner and a custom-designed 13 C imaging sequence. In-vitro [1- 13 C]pyruvate spectroscopic experiments were performed with macrophage-like cell suspensions and an 11·7T magnet. The resulting [1- 13 C]lactate signals from these cell and rodent models were compared with immune cell number (by flow cytometry), phenotype (ELISA), and cytokine gene expression (real-time PCR). Findings: Myocardial infarction caused intense [1- 13 C]lactate signal in healing myocardial segments at both day 3 (maximum inflammatory macrophage phase) and day 7 (reparative phase), compared with sham operated controls. Macrophage depletion normalised the lactate signal at both day 3 and day 7. Mechanistically, polarisation of macrophage suspensions using lipopolysaccharide almost doubled hyperpolarised lactate label flux in vitro; blockade of glycolysisAbstract: Background: Myocardial infarction remains a major killer despite optimised reperfusion systems, highlighting a need for novel therapeutic approaches administered in the days after the event. Inflammation in healing myocardium is one such therapeutic target, though clinical exploration has been hampered by the absence of imaging biomarkers. We hypothesised that metabolic reprogramming in activated macrophages within healing myocardium could be detected by use of hyperpolarised [1- 13 C]pyruvate MRI. Methods: Experimental myocardial infarction was induced in rodents before hyperpolarised [1- 13 C]pyruvate MRI at days 3 or 7, using a 7T MRI scanner and a custom-designed 13 C imaging sequence. In-vitro [1- 13 C]pyruvate spectroscopic experiments were performed with macrophage-like cell suspensions and an 11·7T magnet. The resulting [1- 13 C]lactate signals from these cell and rodent models were compared with immune cell number (by flow cytometry), phenotype (ELISA), and cytokine gene expression (real-time PCR). Findings: Myocardial infarction caused intense [1- 13 C]lactate signal in healing myocardial segments at both day 3 (maximum inflammatory macrophage phase) and day 7 (reparative phase), compared with sham operated controls. Macrophage depletion normalised the lactate signal at both day 3 and day 7. Mechanistically, polarisation of macrophage suspensions using lipopolysaccharide almost doubled hyperpolarised lactate label flux in vitro; blockade of glycolysis with 2-deoxyglucose normalised lactate flux and markedly inhibited production of key proinflammatory cytokines without cytotoxicity. Systemic 2-deoxyglucose after rodent myocardial infarction normalised hyperpolarised [1- 13 C]lactate signal in healing myocardial segments and also improved myocardial inflammatory cytokine levels and remodelling. Interpretation: We show that high hyperpolarised [1- 13 C]lactate signal in the days after myocardial infarction is caused by macrophage-driven inflammation, and reflects not just the number of inflammatory cells infiltrating the myocardium but also the inflammatory phenotype of those cells. Hyperpolarised MRI therefore provides a novel method for the detection of myocardial inflammation with high translational potential as both a biomarker and novel potential pharmacological target. Funding: British Heart Foundation, Oxford British Heart Foundation Centre for Research Excellence. … (more)
- Is Part Of:
- Lancet. Volume 389(2017)Supplement 1
- Journal:
- Lancet
- Issue:
- Volume 389(2017)Supplement 1
- Issue Display:
- Volume 389, Issue 1 (2017)
- Year:
- 2017
- Volume:
- 389
- Issue:
- 1
- Issue Sort Value:
- 2017-0389-0001-0000
- Page Start:
- S62
- Page End:
- Publication Date:
- 2017-02-23
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5 - Journal URLs:
- http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0140-6736(17)30458-0 ↗
- Languages:
- English
- ISSNs:
- 0140-6736
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2271.xml